Methods for systematic reviews of economic evaluations for the Guide to Community Preventive services

American Journal of Preventive Medicine

Volumn 18, Issue 1 SUPPL. 1, 2000, Pages 75-91

  Carande Kulis, Vilma G ^a   Maciosek, Michael V ^b   Briss, Peter A ^a   Teutsch, Steven M ^c   Zaza, Stephanie ^a   Truman, Benedict I ^a   Messonnier, Mark L ^a   Pappaioanou, Marguerite ^a   Harris, Jeffrey R ^a   Fielding, Jonathan ^d  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ARTICLE; COMMUNITY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; HUMAN; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; STANDARDIZATION; TECHNIQUE; VACCINATION;

ABSTRACTING AND INDEXING; ADOLESCENT; ADULT; CHILD; COST-BENEFIT ANALYSIS; DATA COLLECTION; DECISION MAKING; HEALTH CARE COSTS; HUMANS; IMMUNIZATION PROGRAMS; INTERVENTION STUDIES; PRACTICE GUIDELINES; PREVENTIVE HEALTH SERVICES; PROGRAM EVALUATION; UNITED STATES;

EID: 17544390736     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-3797(99)00120-8     Document Type: Article

References (18)

1. US Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore: Williams & Wilkins, 1996.
2. Kassirer JP, Angell M. The Journal's policy on cost-effectiveness analyses. N Engl J Med 1994;331:669-70.
3. Tengs TO, Adams ME, Pliskin JS, et al. Five hundred life-saving interventions and their cost-effectiveness. Risk Anal 1995;15(3):369-90.
4. Ramsberg JAL, Sjöberg L. The cost-effectiveness of life-saving interventions in Sweden. Risk Anal 1997;17:467-78.
5. Graham JD, Corso PS, Morris JM, Segui-Gomez M, Weinstein MC. Evaluating the cost-effectiveness of clinical and public health measures. Ann Rev Pub Health 1998;18:125-53.
6. Schrappe M, Lauterbach K. Systematic review on the cost-effectiveness of public health interventions for HIV prevention in industrialized countries. AIDS 1998;12(suppl):231-7.
7. van der Weijden T, Knottnerus JA, Ament AJ, Stoffers HE, Grol RP. Economic evaluation of cholesterol-related interventions in general practice: an appraisal of the evidence. J Epidemiol Community Health 1998; 52:586-94.
8. Brown ML, Fintor L. Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature. Breast Cancer Res Treat 1993;25:113-8.
9. Pappaioanou M, Evans C. Development of the Guide to Community Preventive Services: a US Public Health Service initiative. J Public Health Mgmt Practice 1998;4:48-54.
10. Zaza S, Wright-De Agüero LK, Briss PA, et al. and the Task Force on Community Preventive Services. Data collection instrument and procedure for systematic reviews in the Guide to Community Preventive Services. AmJ Prev Med 2000;18(suppl 1):44-74.
11. Murray CJL, Lopez AD. Global health statistics. Boston: Harvard University Press, 1996.
12. Briss PA, Rodewald L, Hinman A, et al. and the Task Force on Community Preventive Services. Reviews of evidence for interventions to improve vaccination coverage in children, adolescents and adults. Am J Prev Med 2000;18(suppl 1):97-140.
13. Gold M, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996: Appendix A304-11.
14. Kanavos P, Mossialos E. International comparisons of health care expenditures: what we do know and what we do not know. J Health Services Res Policy 1999;4:122-6.
15. Statistical Abstract of the United States. Washington, DC: US Bureau of the Census, 1997:492-510.
16. Fryback DG, Dasbach EJ, Klein R, Klein BE, Dorn N, et al. The Beaver Dam health outcomes study: initial catalog of health-state quality factors. Med Decis Making 1993;13:89-102.
17. Gold MR, Franks P, McCoy KI, Fryback DG. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care 1998;36:778-92.
18. Margolis HS, Coleman PJ, Brown Re, Mast EE, Sheingold SH, Arevalo JA. Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations. JAMA 1995;274:778-92.